Legacy Pharmaceutical Packaging said it’s recalling 40 lots of Losartan Tablets, which are used to treat heart failure and high blood pressure.
According to a notice posted on the U.S. Food and Drug Administration (FDA) website, the recall was prompted due after “trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA),” which is potentially carcinogenic, was found. It was also triggered due to Camber Pharmaceuticals issuing a voluntary recall of the same medication, manufactured by Hetero Labs in India.
